|
|
Qualitative study on the current status of medication safety in chronic disease patients with long-term medication prescriptions from the perspective of general practitioners |
CHEN Yanxiang1,2 FENG Zhengwen1 HU Yongqiang2 LI Hui1 DU Juan1 |
1.School of General Practice and Continuing Education, Capital Medical University, Beijing 100069, China;
2.Department of General Practice, Changying Community Health Service Center, Beijing 100024, China |
|
|
Abstract Objective To explore the cognition and influencing factors of general practitioners in Beijing urban areas on the current situation of medication safety for chronically ill patients with long-term medication prescriptions, and to put forward reasonable suggestions for formulating medication safety interventions for chronically-ill patients with long-term medication prescriptions in the future. Methods Using the objective sampling method, 16 general practitioners (numbered A to P) from mne community health service centers in Chaoyang District, Beijing were selected as the research subjects. Using the method of one-on-one in-depth interviews, 16 general practitioners were interviewed according to the interview outline from March to June 2021. The content analysis method was used to organize and analyze the data and summarize the interview topics. Results After collating and analyzing the interview data, three themes were extracted. ①There were 10 common medication errors in patients with chronic diseases, such as increasing or decreasing the dose of medication by themselves, repeated medication, wrong medication time and wrong medication method during taking medication. ②The influencing factors that lead to drug safety problems in patients were mainly four aspects including medical staff, patients, families and policy-related factors: doctors’ lack of health education to patients and untimely follow-up; patients’ lack of knowledge and attention to drug use knowledge and skills; timely; insufficient participation of family members; untimely supply of some long-term mediation prescription drugs leads to interruption of patients’ medication and inconsistent specifications and quantities of drugs prescribed by various pharmaceutical factory directors, which indirectly affects the safety of patients’ medication. ③Various measures should be taken to improve the safety of patients’ medication. The main measures include strengthening medication safety education for patients, regular follow-up visits, and encouraging family members to participate and support. Conclusion The drug safety problem of chronically ill long-term mediation prescription patients is prominent, and the collaborative role of the family doctor’s service team should be brought into full play, and patients and family members should be encouraged to participate in drug management. The policy guarantees the unification of the supply of some long-prescription drugs and the number of drugs in each box, improves patient compliance with medication, improves patient medication safety, and promotes the further implementation of the long-prescription policy.
|
|
|
|
|
[1] 国家医保局.《国家医疗保障局办公室关于优化医疗保障经办服务 推动新型冠状病毒感染的肺炎疫情防控工作的通知》[EB/OL].(2020-02-02)[2020-03-01].http://www.nhsa.gov.cn/art/2020/2/2/art_37_2325.html.
[2] 陈小青,陈伯梅,胡国彬,等.慢性病长处方管理模式的现状与未来发展[J].中医药管理杂志,2021,29(20):229-231.
[3] 国务院办公厅.《国务院办公厅关于推进分级诊疗制度建设的指导意见》(国办发〔2015〕70号)[EB/OL].(2015-09-11)[2020-03-02]. http://www.gov.cn/zhengce/content/2015-09/11/content_10158.htm.
[4] 翁立立,陆萍,沈宏祥.推广长处方对慢性病患者社区就诊意愿的影响分析[J].上海医药,2017,38(24):12-14.
[5] 马健,傅鸿鹏.慢性疾病患者对长处方政策的使用和认知情况调查[J].中国药物经济学,2018,13(8):16-20.
[6] 刘昉,马健,傅鸿鹏.社区卫生服务机构人员对长处方政策的认知调查[J].卫生经济研究,2018(5):54-56.
[7] Committee of Experts on Management of Safety and Quality in Health Care. Glossary of terms related to patient and medication safety [EB/OL].(2005-10-20)[2020-12-10].http://www.who.int/patientsafety/highlights/COE_patient_ and_medication_safety_gl.pdf.
[8] 杨世民.药事管理与法规[M].北京:高等教育出版社,2010.
[9] Leung DY,Bai X,Leung AY,et al. Prevalence of medication adherence and its associated factors among community-dwelling Chinese older adults in Hong Kong [J]. Geriatr Gerontol Int,2015,15(6):789-796.
[10] 王彧杰,原永芳.慢病患者长处方的安全性评价[J].中南药学,2021,19(10):2189-2193.
[11] 孙雯娟,陈浩,Zhang H,等.英国重配处方项目运作中的安全隐患及防范概述[J].中国药师,2014,17(8):1388-1393.
[12] Siaw MYL,Toh JH,Lee JY. Patients’ perceptions of pharmacist-managed diabetes services in the ambulatory care and community settings within Singapore [J]. Int J Clin Pharm,2018,40(2):403-411.
[13] 张楠,张娜,鲁秀玲,等.医联体药师团队参与COPD患者长期用药安全评估管理工作模式的实践研究[J].中国药师,2018,21(3):441-444.
[14] 黄桂好,梁蔚莉.家庭医生签约式服务对社区老年慢性病患者用药依从性的影响探讨[J].现代诊断与治疗,2018,29(3):493-494.
[15] 刘士勇,郗海香.基于高血压病诊疗实践的慢性病长处方签约服务的效果[J].慢性病学杂志,2021,22(7):1058-1060.
[16] 国家卫生健康委办公厅,国家医保局办公室.《关于印发长期处方管理规范(试行)的通知》(国卫办医发〔2021〕17号)[EB/OL].(2021-08-10)[2021-09-27]. http://www.gov.cn/zhengce/zhengceku/2021-08/13/content_563 1140.htm.
[17] 刘洋,刘鑫,李亚利,等.北京市社区高血压长处方患者慢病管理的药学服务模式评价[J].临床药物治疗杂志,2018,16(10):78-80,89.
[18] 曹伟灵,庄沿磊,叶陈丽,等.社区健康服务中心开展慢性病长期处方的现状及可行性研究[J].今日药学,2020, 30(8):573-576.
[19] 王冰寒,颜巧元,刘义兰,等.患者参与用药安全的研究进展[J].中国护理管理,2018,18(6):817-821.
[20] Kim JM,Suarez-Cuervo C,Berger Z,et al. Evaluation of Patient and Family Engagement Strategies to Improve Medication Safety [J]. Patient,2018,11(2):193-206.
[21] 张慧,万琼.高血压患者参与用药安全知信行现况调查[J].中西医结合心血管病电子杂志,2019,7(33):197-198.
[22] 张慧玲.居家老年心血管病患者参与用药安全管理方案及应用研究[D].郑州:郑州大学,2017.
[23] 周宇,刘梦雅,高莉莉,等.基于信息化的服药依从性促进工具研究进展[J].护理研究,2020,34(23):4186-4190.
[24] Carman KL,Dardess P,Maurer M,et al. Patient and family engagement:a framework for understanding the elements and developing interventions and policies [J]. Health Aff (Millwood),2013,32(2):223-231.
[25] 许晶晶,姚平立,宋海宁,等.我院门诊药房药品拆零管理存在的问题与改进措施[J].中国医药导报,2018,15(22):150-153. |
|
|
|